← Leaderboards
Eric Martin McDade
Washington University
$99,265,332
Attributed
$99,692,778
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $22.9M · FY2015–25$25M$18.8M$12.5M$6.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$99,692,778 · 4
By mechanism
U01$97,939,599 · 1
T32$854,892 · 1
K23$676,593 · 1
R13$221,694 · 1
Top collaborators
- Barbara Joy Snider2 shared
Most similar at Washington University
Same institution · by research overlap
- Guojun Bu$30,610,787
- John Morris$91,785,862
- David M Holtzman$51,909,630
- Celeste Marie Karch$19,357,585
- Anne Fagan Niven$12,288,829
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposParticipantSymptomsFundingPreventS DiseaseDementiaPositioning AttributePositron-Emission TomographyFoundationsBiological MarkersAmyloidAmyloid DepositionCognitivePathologicOutcome StudyAmyloidosisSitePathologyAmyloid Beta-ProteinImpaired CognitionClinical TrialsDesignMutation Carrier
Grant awards (26)
DIAN-TU Primary Prevention Trial$15,677,887
U01 · FY2025 · AG · contact PI
Multidisciplinary Training in Alzheimer and Related Dementias$427,862
T32 · FY2025 · AG
DIAN-TU Primary Prevention Trial$346,607
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$185,081
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$157,240
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$156,353
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$131,067
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$119,184
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$113,450
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$113,450
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$104,277
U01 · FY2025 · AG · contact PI
DIAN-TU Primary Prevention Trial$22,429,727
U01 · FY2024 · AG · contact PI
Multidisciplinary Training in Alzheimer and Related Dementias$427,030
T32 · FY2024 · AG
DIAN-TU Primary Prevention Trial$20,263,304
U01 · FY2022 · AG · contact PI
DIAN-TU Primary Prevention Trial NfL Characterization Admin Supp$293,537
U01 · FY2022 · AG · contact PI
DIAN-TU Primary Prevention Trial$17,695,782
U01 · FY2021 · AG · contact PI
DIAN-TU Primary Prevention Trial$1,586,508
U01 · FY2021 · AG · contact PI
Cerebrovascular Reactivity in the Presence of Cerebral Amyloid and Cerebrovascular Disease: A novel multi-modal imaging measure of vascular reserve in cognitively normal elderly$114,960
K23 · FY2019 · AG · contact PI
The Dominantly Inherited Alzheimer Disease Family Conference$73,898
R13 · FY2019 · AG · contact PI
DIAN-TU Primary Prevention Trial$18,566,145
U01 · FY2018 · AG · contact PI
Cerebrovascular Reactivity in the Presence of Cerebral Amyloid and Cerebrovascular Disease: A novel multi-modal imaging measure of vascular reserve in cognitively normal elderly$122,022
K23 · FY2018 · AG · contact PI
The Dominantly Inherited Alzheimer Disease Family Conference$73,898
R13 · FY2018 · AG · contact PI
Cerebrovascular Reactivity in the Presence of Cerebral Amyloid and Cerebrovascular Disease: A novel multi-modal imaging measure of vascular reserve in cognitively normal elderly$137,591
K23 · FY2017 · AG · contact PI
The Dominantly Inherited Alzheimer Disease Family Conference$73,898
R13 · FY2017 · AG · contact PI
Cerebrovascular Reactivity in the Presence of Cerebral Amyloid and Cerebrovascular Disease: A novel multi-modal imaging measure of vascular reserve in cognitively normal elderly$150,200
K23 · FY2016 · AG · contact PI
Cerebrovascular Reactivity in the Presence of Cerebral Amyloid and Cerebrovascular Disease: A novel multi-modal imaging measure of vascular reserve in cognitively normal elderly$151,820
K23 · FY2015 · AG · contact PI